![Chris Hollowood](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chris Hollowood
Direttore/Membro del Consiglio presso
APPLIED GENETIC TECHNOLOGIES CORPORATION
Profilo
Christopher John Hollowood is the founder of Spur Therapeutics Ltd., founded in 2015, holding the title of Director since 2026.
Current jobs include Chief Executive Officer at Syncona Partners LLP since 2023 (job started in 2012), Chairman at Forcefield Therapeutics Ltd. since 2020, Director at Beacon Therapeutics (USA), Inc. since 2022, and Director at Syncona Ip Holdco Ltd. Former jobs include Chairman at Nightstar Therapeutics Ltd. from 2013 to 2019, Chairman at Gyroscope Therapeutics Ltd. from 2016 to 2022, Chairman at SwanBio Therapeutics, Inc. from 2018 to 2023, Chairman at Gyroscope Therapeutics Holdings Plc from 2016 to 2022, Director at Bird Rock Bio Sub, Inc., Director at Convergence Pharmaceuticals Ltd. from 2010 to 2012, Director at Calchan Holdings Ltd., Director at NightstaRx Ltd., Director at Purespring Therapeutics Ltd., Independent Director at Freeline Therapeutics Holdings Ltd., Managing Partner at Syncona Ltd., Chief Investment Officer at Syncona Ltd., and Partner at Apposite Capital LLP from 2010 to 2012.
Education includes a doctorate from the University of Cambridge, conferred in 1996.
Posizioni attive di Chris Hollowood
| Società | Posizione | Inizio |
|---|---|---|
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Direttore/Membro del Consiglio | 01/12/2022 |
Forcefield Therapeutics Ltd.
 Forcefield Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics to retain heart function via protection of cardiomyocytes | Presidente | 01/11/2020 |
Syncona Ip Holdco Ltd. | Direttore/Membro del Consiglio | - |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which developing gene therapies for bleeding and other debilitating disorders | Fondatore | 01/01/2015 |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Amministratore Delegato | 01/01/2023 |
Precedenti posizioni note di Chris Hollowood
| Società | Posizione | Fine |
|---|---|---|
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage gene therapy company that develops therapeutics for neurological disorders | Presidente | 16/10/2023 |
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Presidente | 17/02/2022 |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Presidente | 02/02/2022 |
| NIGHTSTAR THERAPEUTICS PLC | Presidente | 07/06/2019 |
| ░░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formazione di Chris Hollowood
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
81
Relazioni di 1° grado
18
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 18 |
|---|---|
Syncona Ltd.
 Syncona Ltd. Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development company that provides gene therapy development & clinical research services | Health Technology |
Apposite Capital LLP
 Apposite Capital LLP Investment ManagersFinance Apposite Capital invests in companies located in the United Kingdom and European with revenues of up to EUR 100 million. The firm focuses on the technology sector. It provides financing for MBOs, buy-ins and growth capital requirements. It also acquires minority interest. | Finance |
Bird Rock Bio Sub, Inc.
 Bird Rock Bio Sub, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Convergence Pharmaceuticals Ltd.
 Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops neuropathic pain products | Health Technology |
Calchan Holdings Ltd.
 Calchan Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops novel oral state-dependent calcium channel (CaV 2.2) modulators for chronic pain | Health Technology |
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Finance |
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services development of therapies for retinal dystrophies | Health Services |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which developing gene therapies for bleeding and other debilitating disorders | Health Technology |
Nightstar Therapeutics Ltd.
 Nightstar Therapeutics Ltd. BiotechnologyHealth Technology Operates as a gene therapy company that develops novel treatments for patients suffering from inherited retinal diseases | Health Technology |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Health Technology |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage gene therapy company that develops therapeutics for neurological disorders | Health Technology |
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Develops and manufactures next-generation gene therapies | Health Technology |
Purespring Therapeutics Ltd.
 Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases | Health Technology |
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Develops clinical-stage gene therapies to treat diseases of eyes | Health Technology |
Forcefield Therapeutics Ltd.
Forcefield Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics to retain heart function via protection of cardiomyocytes | Health Technology |
Syncona Ip Holdco Ltd. |
